Incyclix Bio: Funding, Investors & Team (Oct 2026)
Incyclix Bio was established in 2020 in Durham, North Carolina by Patrick Roberts, Jay Strum, John Bisi, and Fred Eshelman. The company specializes in creating small molecule inhibitors of CDKs for the treatment of advanced and drug-resistant cancers.
Incyclix Bio has raised $16.2M across 2 funding rounds on record, the most recent a Series B of $5.0M announced in Apr 2026.
That round is below the $8.6M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Incyclix Bio Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Incyclix Bio Funding Rounds
Incyclix Bio raised $11.2M in a Series B announced in Aug 2025.
8 months later, a Series B of $5.0M was announced in Apr 2026.
Incyclix Bio Founders and Leadership Team
Contact details for the Incyclix Bio team: 2 of 2 have an email address on file.
Start 14-day free trial →Incyclix Bio Funding Compared to Other Biotechnology Startups
Incyclix Bio's latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Incyclix Bio in Biotechnology and Durham
Companies Similar to Incyclix Bio
Arctic Therapeutics specializes in finding the genetic origins of common diseases and creating successful…
100XBIO is creating a cutting-edge platform for analyzing multiple T-cells automatically, aiming to…
MEND is a company focused on life sciences, determined to assist individuals in achieving better health…
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Incyclix Bio Funding FAQs
What does Incyclix Bio do?
Incyclix Bio was established in 2020 in Durham, North Carolina by Patrick Roberts, Jay Strum, John Bisi, and Fred Eshelman. The company specializes in creating small molecule inhibitors of CDKs for the treatment of advanced and drug-resistant cancers.
How much funding has Incyclix Bio raised?
Incyclix Bio has raised $16.2M across 2 rounds on record. The most recent is a Series B of $5.0M announced in Apr 2026.
When did Incyclix Bio last raise funding?
Incyclix Bio's most recent funding round on record is a Series B of $5.0M, announced in Apr 2026.
Who founded Incyclix Bio?
FundedIQ lists John Bisi (Founder), Patrick Roberts (Founder) at Incyclix Bio.
Where is Incyclix Bio headquartered?
Incyclix Bio is based in Durham, North Carolina, United States.
How many employees does Incyclix Bio have?
Incyclix Bio is in the 11-50 employee band.
How does Incyclix Bio's funding compare to other Biotechnology startups?
Incyclix Bio's latest round of $5.0M is below the $8.6M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Incyclix Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Incyclix Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.